Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Functional Stability of Organic and Inorganic Modified Luminescent Lyocell Fibers for Security Applications.

Materials (Basel, Switzerland)·2026
Same author

The Influence of Plastic Processing on the Corrosion Resistance of the Alloy Based on the FeAl Intermetallic Phase After Long-Term Oxidation in Air Atmosphere.

Materials (Basel, Switzerland)·2026
Same author

Comparison of Oxide Scale Morphology on FeAl-Based Alloy After Long-Term Oxidation in Air and Water Vapor at 700 °C.

Materials (Basel, Switzerland)·2026
Same author

The potential of ancient medicine - using products from snails in treatment of oncology patients.

Annals of agricultural and environmental medicine : AAEM·2026
Same author

ADMET-Guided Design and In Silico Planning of Boron Delivery Systems for BNCT: From Transport and Biodistribution to PBPK-Informed Irradiation Windows.

Molecules (Basel, Switzerland)·2026
Same author

Evidence of <i>Babesia microti</i> penetration of hepatocytes based on <i>in vitro</i> and <i>in vivo</i> studies.

Annals of agricultural and environmental medicine : AAEM·2025
Same journal

Evidence-Based Clinical Recommendations for the Appropriate Use of Diagnostic Tests in Pediatric Allergology: Focus on Asthma, Rhinoconjunctivitis, and Keratoconjunctivitis Vernal.

Journal of clinical medicine·2026
Same journal

Surgical and Transcatheter Approach of a Failed Mitral Valve Repair: A Comprehensive Review on Selecting the Most Suitable Approach.

Journal of clinical medicine·2026
Same journal

Hybrid Metaheuristic Feature Selection for Breast Cancer Detection in Digital Mammography: A Feasibility Study with Nested Validation, Benchmarking, and External Stress Testing.

Journal of clinical medicine·2026
Same journal

Identity Transformation and the Role of Accountability in Recovery from Problematic Pornography Use: A Phenomenological-Hermeneutical Study.

Journal of clinical medicine·2026
Same journal

Does Early Surgical Treatment in Degenerative Cervical Myelopathy Have a Favorable Clinical Outcome and Impact on Quality of Life?

Journal of clinical medicine·2026
Same journal

Shear Wave Elastography in Musculoskeletal Imaging: A Narrative Review.

Journal of clinical medicine·2026
See all related articles

Related Experiment Video

Updated: Jul 5, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.4K

Enhancing Patient Selection in Stage IIIA-IIIB NSCLC: Invasive Lymph Node Restaging after Neoadjuvant Therapy.

Robert Kwiatkowski1, Marcin Zieliński2, Jarosław Paluch3

  • 1Radiotherapy Department, Katowickie Centrum Onkologii, 40-074 Katowice, Poland.

Journal of Clinical Medicine
|January 23, 2024
PubMed
Summary
This summary is machine-generated.

Invasive restaging of mediastinal lymph nodes using EBUS, EUS, and TEMLA significantly improves survival for stage IIIA-IIIB Non-Small-Cell Lung Cancer (NSCLC) patients after neoadjuvant therapy. This approach enhances patient selection for surgery, leading to better overall survival rates.

Keywords:
Non-Small-Cell Lung Cancerneoadjuvant therapypneumonectomy

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

1.9K

Related Experiment Videos

Last Updated: Jul 5, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.4K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

1.9K

Area of Science:

  • Thoracic Surgery
  • Oncology
  • Pulmonology

Background:

  • Accurate staging of mediastinal lymph nodes is critical for multimodal treatment of stage IIIA Non-Small-Cell Lung Cancer (NSCLC).
  • Neoadjuvant chemotherapy (CHT) or chemoradiotherapy (CRT) is often used for patients with clinical stage IIIA-IIIB NSCLC and N2 disease.
  • Assessing the effectiveness of restaging methods after neoadjuvant therapy is essential for optimizing treatment strategies.

Purpose of the Study:

  • To evaluate the impact of restaging mediastinal lymph nodes using endobronchial ultrasound (EBUS), endoesophageal ultrasound (EUS), and transcervical extended mediastinal lymphadenectomy (TEMLA) after neoadjuvant therapy.
  • To compare the 5-year overall survival (OS) rates between patients restaged with invasive methods versus chest CT scan-only.
  • To determine if invasive restaging improves patient selection for radical pulmonary resections in NSCLC.

Main Methods:

  • Retrospective analysis of stage IIIA-IIIB NSCLC patients with N2 mediastinal nodes who underwent radical pulmonary resection.
  • Patients were divided into two groups: TEMLA restaging and chest CT scan-only.
  • Primary outcome was 5-year OS; secondary outcomes included median OS and survival percentages. Log-rank test was used for statistical analysis.

Main Results:

  • The TEMLA restaging group showed significantly better 5-year OS rates compared to the chest CT scan-only group (p = 0.003).
  • Median OS was four-fold higher in the TEMLA group (59 months) versus the CT-only group (14 months).
  • 5-year OS was 55.9% in the TEMLA group versus 25.0% in the CT-only group.

Conclusions:

  • Invasive restaging of mediastinal lymph nodes (EBUS, EUS, TEMLA) significantly improves patient selection for surgery in stage IIIA-IIIB (N2) NSCLC after neoadjuvant therapy.
  • These methods provide crucial information for identifying N2 to N0-1 downstaging, indicating suitability for radical resection.
  • Incorporating invasive restaging into treatment decisions is vital for optimizing outcomes in NSCLC patients with mediastinal lymph node involvement.